Skip to main content
Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
35.05
-0.05 (-0.14%)
At close: Dec 5, 2025, 4:00 PM EST
34.37
-0.68 (-1.94%)
After-hours: Dec 5, 2025, 5:03 PM EST

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 2018 - 2020
Period Ending
 Sep '25 Sep '24 Sep '23 Sep '22 2018 - 2020
United States Revenue
-
Log In
Log In
Log In
Upgrade
Africa Revenue
-
Log In
Log In
Log In
Upgrade
China Revenue
-
Log In
Log In
Log In
Upgrade
United Kingdom Revenue
-
Log In
Log In
Log In
Upgrade
Rest of Europe Revenue
-
Log In
Log In
Log In
Upgrade
Asia Pacific/ Other Revenue
-
Log In
Log In
Log In
Upgrade
Revenue (Other)
593.82M
Log In
Log In
Log In
Upgrade
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Revenue Breakdown

Fiscal year is October - September.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 2018 - 2020
Period Ending
 Sep '25 Sep '24 Sep '23 Sep '22 2018 - 2020
Sample Management Solutions Revenue
325.00M
Log In
Log In
Log In
Upgrade
Multiomics Revenue
269.00M
Log In
Log In
Log In
Upgrade
B Medical Revenue
-
Log In
Log In
Log In
Upgrade
Revenue (Other)
-179.00K
Log In
Log In
Log In
Upgrade
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Fiscal year is October - September.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 2018 - 2020
Period Ending
 Sep '25 Sep '24 Sep '23 Sep '22 2018 - 2020
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 3

Fiscal year is October - September.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 2018 - 2020
Period Ending
 Sep '25 Sep '24 Sep '23 Sep '22 2018 - 2020
Multiomics Revenue
269.00M
Log In
Log In
Log In
Upgrade
Core Products Revenue
-
Log In
Log In
Log In
Upgrade
Sample Repository Solutions Revenue
-
Log In
Log In
Log In
Upgrade
B Medical Revenue
-
Log In
Log In
Log In
Upgrade
Revenue (Total)
593.82M
Log In
Log In
Log In
Upgrade

Adjusted EBIT

Fiscal year is October - September.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 2018 - 2020
Period Ending
 Sep '25 Sep '24 Sep '23 Sep '22 2018 - 2020
Sample Management Solutions Adjusted Operating Income
27.55M
Log In
Log In
Log In
Upgrade
Multiomics Adjusted Operating Income
-11.94M
Log In
Log In
Log In
Upgrade
B Medical Systems Adjusted Operating Income
-
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-42.46M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-26.84M
Log In
Log In
Log In
Upgrade

Adjusted EBIT 2

Fiscal year is October - September.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 2018 - 2020
Period Ending
 Sep '25 Sep '24 Sep '23 Sep '22 2018 - 2020
Life Sciences Product Adjusted Operating Income
-
Log In
Log In
Log In
Upgrade
Life Sciences Services Adjusted Operating Income
-
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-26.84M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Fiscal year is October - September.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 2018 - 2020
Period Ending
 Sep '25 Sep '24 Sep '23 Sep '22 2018 - 2020
Organic Revenue Growth
3.00%
Log In
Log In
Log In
Upgrade